- Home
- CRVO vs FONR Comparison
CRVO vs FONR Comparison
Compare CRVO & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- FONR
- Stock Information
- Founded
- CRVO 2001
- FONR 1978
- Country
- CRVO United States
- FONR United States
- Employees
- CRVO N/A
- FONR N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRVO Health Care
- FONR Health Care
- Exchange
- CRVO Nasdaq
- FONR Nasdaq
- Market Cap
- CRVO 95.4M
- FONR 94.1M
- IPO Year
- CRVO N/A
- FONR 1987
- Fundamental
- Price
- CRVO $8.91
- FONR $13.59
- Analyst Decision
- CRVO Strong Buy
- FONR
- Analyst Count
- CRVO 8
- FONR 0
- Target Price
- CRVO $25.43
- FONR N/A
- AVG Volume (30 Days)
- CRVO 13.3M
- FONR 11.6K
- Earning Date
- CRVO 03-17-2025
- FONR 05-14-2025
- Dividend Yield
- CRVO N/A
- FONR N/A
- EPS Growth
- CRVO N/A
- FONR N/A
- EPS
- CRVO N/A
- FONR 1.17
- Revenue
- CRVO $9,737,974.00
- FONR $101,570,089.00
- Revenue This Year
- CRVO N/A
- FONR N/A
- Revenue Next Year
- CRVO N/A
- FONR N/A
- P/E Ratio
- CRVO N/A
- FONR $11.68
- Revenue Growth
- CRVO 36.29
- FONR N/A
- 52 Week Low
- CRVO $1.80
- FONR $13.27
- 52 Week High
- CRVO $25.92
- FONR $22.20
- Technical
- Relative Strength Index (RSI)
- CRVO 63.30
- FONR 35.51
- Support Level
- CRVO $8.53
- FONR $13.70
- Resistance Level
- CRVO $16.94
- FONR $13.99
- Average True Range (ATR)
- CRVO 2.01
- FONR 0.33
- MACD
- CRVO 0.66
- FONR 0.02
- Stochastic Oscillator
- CRVO 50.33
- FONR 22.70
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.